Ultrasound-guided percutaneous polidocanol ablation for symptomatic benign cystic and predominantly cystic thyroid nodules: a prospective evaluation of safety and efficacy

Abstract Aim of the study This study aimed to evaluate the safety and efficacy of ultrasound-guided percutaneous polidocanol ablation for the treatment of symptomatic benign cystic and predominantly cystic thyroid nodules. Methods This six-month prospective single-arm interventional trial was carried out at Ain Shams University Hospitals between March 2025 and August 2025. A sample of 30 patients of mean age (37.70 ± 9.92 years) with cystic or primarily cystic thyroid nodules (fluid percentage >50%) and benign cytology results were enrolled. Under ultrasound guidance, cystic content was aspirated and the cavity irrigated with saline before slowly injecting Polidocanol foam (30–50% of aspirated volume). The volume reduction rate (VRR), a visual analog scale for pressure symptoms, and a four-point cosmetic assessment were used to evaluate clinical results at 1, 3, and 6 months following the treatment. Results The study population was predominantly female (70%). The average mean initial nodule volume was 20.93 ± 13.70 cc. At the six-month check-in, the average VRR was 62.92 ± 23.69%, with 70% of patients achieving a successful outcome (VRR >50%). Pure cystic nodules showed a 75% success rate, while a lower success rate of 67% for those with a solid component. Despite the fact that this difference was not statistically significant ( P > 0.05), over the course of the follow-up period, there were notable changes in the median compression score ( P < 0.0001) and cosmetic score ( P < 0.001). Only temporary mild-to-moderate local pain was noted in 20% of cases; there were no significant consequences. Conclusion Ultrasound-guided percutaneous polidocanol ablation is a safe and efficient outpatient treatment option for benign cystic thyroid nodules that cause symptoms instead of surgery. The existence of a solid component can restrict therapeutic efficiency and may require many treatment sessions, even though it is quite effective for pure cysts.

Authors

Publication Details

Journal
The Egyptian Journal of Radiology and Nuclear Medicine
Published
2026-09-29
DOI
https://doi.org/10.1186/s43055-026-01876-z
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Ultrasound-guided percutaneous polidocanol ablation for symptomatic benign cystic and predominantly cystic thyroid nodules: a prospective evaluation of safety and efficacy

Mai Shaaban Abd El-Galil, Sameh Mohammed Abdelwahab, Wael Maher Mohamed Abd El Khalek, Mohamed Osama Mohammad Kamel Abdelmawla
The Egyptian Journal of Radiology and Nuclear Medicine
Thyroid Cancer Diagnosis and Treatment
article

Ultrasound-guided percutaneous polidocanol ablation for symptomatic benign cystic and predominantly cystic thyroid nodules: a prospective evaluation of safety and efficacy

Mai Shaaban Abd El-Galil, Sameh Mohammed Abdelwahab, Wael Maher Mohamed Abd El Khalek, Mohamed Osama Mohammad Kamel Abdelmawla
article en

Abstract

Abstract Aim of the study This study aimed to evaluate the safety and efficacy of ultrasound-guided percutaneous polidocanol ablation for the treatment of symptomatic benign cystic and predominantly cystic thyroid nodules. Methods This six-month prospective single-arm interventional trial was carried out at Ain Shams University Hospitals between March 2025 and August 2025. A sample of 30 patients of mean age (37.70 ± 9.92 years) with cystic or primarily cystic thyroid nodules (fluid percentage >50%) and benign cytology results were enrolled. Under ultrasound guidance, cystic content was aspirated and the cavity irrigated with saline before slowly injecting Polidocanol foam (30–50% of aspirated volume). The volume reduction rate (VRR), a visual analog scale for pressure symptoms, and a four-point cosmetic assessment were used to evaluate clinical results at 1, 3, and 6 months following the treatment. Results The study population was predominantly female (70%). The average mean initial nodule volume was 20.93 ± 13.70 cc. At the six-month check-in, the average VRR was 62.92 ± 23.69%, with 70% of patients achieving a successful outcome (VRR >50%). Pure cystic nodules showed a 75% success rate, while a lower success rate of 67% for those with a solid component. Despite the fact that this difference was not statistically significant ( P > 0.05), over the course of the follow-up period, there were notable changes in the median compression score ( P < 0.0001) and cosmetic score ( P < 0.001). Only temporary mild-to-moderate local pain was noted in 20% of cases; there were no significant consequences. Conclusion Ultrasound-guided percutaneous polidocanol ablation is a safe and efficient outpatient treatment option for benign cystic thyroid nodules that cause symptoms instead of surgery. The existence of a solid component can restrict therapeutic efficiency and may require many treatment sessions, even though it is quite effective for pure cysts.

The Egyptian Journal of Radiology and Nuclear MedicineVol. 57(1)
Good health and well-being
Openalex Percentile: Top 11%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ultrasound-guided percutaneous polidocanol ablation for symptomatic benign cystic and predominantly cystic thyroid nodules: a prospective evaluation of safety and efficacy — Mai Shaaban Abd El-Galil, Sameh Mohammed Abdelwahab, et al. · The Egyptian Journal of Radiology and Nuclear Medicine (2026) | TGRS Research Map | TGRS